
IndraLab
Statements
reach
"We found that the selective epidermal growth factor receptor (EGFR) kinase inhibitor AG556 (10 muM), but not the platelet growth factor receptor (PDGFR) kinase inhibitor AG1295 (10 muM) or the Src family inhibitor PP2 (10 muM), can inhibit hEAG1 current, and the inhibitory effect can be reversed by the protein tyrosine phosphatase (PTP) inhibitor orthovanadate."